Implantable Ports Market Analysis | United States | 2016-2022 | MedCore

Implantable Ports Market Analysis | United States | 2016-2022 | MedCore

0

The U.S. market for implantable ports comprises conventional implantable ports, power-injectable
implantable ports and valved implantable ports. Conventional implantable ports are defined as
implantable ports that do not feature power-injection. Valved implantable ports are designed to
prevent the backflow of blood and reduce catheter-related complications.

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Published Date: 5/1/2016
  • Pages: 172
  • Type: MedCore

The U.S. market for implantable ports comprises conventional implantable ports, power-injectable implantable ports and valved implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. Valved implantable ports are designed to prevent the backflow of blood and reduce catheter-related complications. Power-injectable ports became available in the U.S. in 2007 and allowed the total implantable port market to be further segmented into conventional and power-injectable models. Valved ports are also present in the U.S. market but there is only one company manufacturing them, and the devices have a limited penetration in the total implantable port market.



The "US Market Report Suite for Vascular Access Devices and Accessories 2016 - MedSuite" includes analysis on the following companies currently active in this market:
3M
Access Scientific
Allison Medical
Analogic
AngioDynamics
Argon Medical
B. Braun
Baxter
Becton Dickinson
C.R. Bard
Cardinal Health
Centurion
Churchill Medical Systems
Cook Medical
Delta Hi-Tech, Inc.
Esaote North America
EXEL International
FUJIFILM SonoSite, Inc.
GaltNeedleTech
GE Healthcare
Interrad Medical
Kawasumi
Medcomp
Medical Plastic Devices, Inc.
Medikit
Medtronic
Mindray
MPS Medical
MYCO Medical
Neo Medical
Nipro Medical
Novo Nordisk
Owen Mumford, Inc.
Perrigo
PFM Medical
Phase One Medical
Protectus Medical Devices
ReliOn
Retractable Technologies, Inc.
Revolutions Medical
Safety 1st Medical
Siemens Medical Solutions
SIUI
Smiths Medical
SOL-MILLENNIUM
SonoScape
Starboard
Teleflex Medical

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link